SCHEMBL7351338

SCHEMBL7351338

O[C@@H]1C=CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7346799 1.00
SCHEMBL107504 1.00
Cyclohexene SCHEMBL8175251 0.95
SCHEMBL14612282 0.92
SCHEMBL1071594 0.92
Bicarbonate SCHEMBL5180989 0.90 POLB (0.31)
SCHEMBL25161927 0.89
SCHEMBL1535243 0.89 TSHR (0.32)
SCHEMBL1072262 0.89
SCHEMBL11613169 0.89 TSHR (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0559656-A1 PROCESS FOR PREPARING MULTICYCLIC OXY-CONTAINING RING COMPONENTS RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1993-09-15 EP claimed
WO-1992009592-A1 PROCESS FOR PREPARING MULTICYCLIC OXY-CONTAINING RING COMPONENTS RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-06-11 WO claimed
US-20220380309-A1 CHOLINE METABOLISM INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2022-12-01 US disclosed
WO-2021062168-A1 SYNTHETIC SPHINGOLIPID INSPIRED MOLECULES WITH HETEROAROMATIC APPENDAGES, METHODS OF THEIR SYNTHESIS AND METHODS OF TREATMENT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-04-01 WO disclosed
WO-2020117942-A1 CHOLINE METABOLISM INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2020-06-11 WO disclosed
WO-2020117942-A1 CHOLINE METABOLISM INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2020-06-11 WO disclosed
US-20140323418-A1 SELECTIVE KINASE INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2014-10-30 US disclosed
US-20140323418-A1 SELECTIVE KINASE INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2014-10-30 US disclosed
US-7820862-B2 Ligand, method for producing the same, and catalyst using the ligand THE UNIVERSITY OF TOKYO (JP) 2010-10-26 US disclosed
US-7820862-B2 Ligand, method for producing the same, and catalyst using the ligand THE UNIVERSITY OF TOKYO (JP) 2010-10-26 US disclosed
US-20090023579-A1 Ligand, Method for Producing the Same, and Catalyst Using the Ligand THE UNIVERSITY OF TOKYO (JP) 2009-01-22 US disclosed
EP-1741740-A1 POLYMER HAVING OXOCARBON GROUP AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2007-01-10 EP disclosed
EP-0891359-A1 NOVEL OXAZOLIDINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND MEDICAMENTS CONTAINING THEM Roche Diagnostics GmbH (DE) 1999-01-20 EP disclosed
WO-1997036899-A1 NOVEL OXAZOLIDINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND MEDICAMENTS CONTAINING THEM BOEHRINGER MANNHEIM GMBH (DE) 1997-10-09 WO disclosed
US-H1406-H Process for preparing dibenzofurans via catalytic heteroannulation RHONE POULENC RORER PHARMACEUTICALS INC. (US) 1995-01-03 US disclosed
US-5278323-A Process for preparing chiral dibenzofurans via intramolecular heck reaction RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1994-01-11 US disclosed
EP-0559656-A1 PROCESS FOR PREPARING MULTICYCLIC OXY-CONTAINING RING COMPONENTS RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1993-09-15 EP disclosed
WO-1992009592-A1 PROCESS FOR PREPARING MULTICYCLIC OXY-CONTAINING RING COMPONENTS RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-06-11 WO disclosed
EP-0213547-B1 CYCLOHEXANEALKANOIC ACIDS MERRELL DOW PHARMACEUTICALS INC. (US) 1990-12-27 EP disclosed
US-4622422-A FOR TREATMENT OF BRONCHIAL ASTHMA MERRELL DOW PHARMACEUTICALS INC. (US) 1986-11-11 US disclosed